Healthpeak Properties (NYSE:DOC – Get Free Report) was upgraded by stock analysts at Evercore ISI to a “strong-buy” rating in a research note issued on Monday, Zacks.com reports.
DOC has been the subject of several other research reports. Scotiabank boosted their target price on Healthpeak Properties from $22.00 to $23.00 and gave the stock a “sector outperform” rating in a research note on Thursday, May 16th. BNP Paribas upgraded Healthpeak Properties from a “neutral” rating to an “outperform” rating and boosted their target price for the stock from $19.00 to $21.00 in a research note on Friday, April 26th. Mizuho restated a “buy” rating and set a $22.00 target price on shares of Healthpeak Properties in a research note on Monday, April 22nd. Wedbush lifted their price target on Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Monday. Finally, Argus raised Healthpeak Properties to a “strong-buy” rating in a research report on Thursday, May 9th. Six investment analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $20.64.
Healthpeak Properties Stock Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). The firm had revenue of $695.50 million for the quarter, compared to analysts’ expectations of $665.11 million. Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. The business’s revenue was up 27.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.45 earnings per share. As a group, sell-side analysts forecast that Healthpeak Properties will post 1.79 earnings per share for the current year.
Hedge Funds Weigh In On Healthpeak Properties
Several institutional investors have recently added to or reduced their stakes in the business. B. Riley Wealth Advisors Inc. increased its stake in Healthpeak Properties by 36.4% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 23,793 shares of the real estate investment trust’s stock worth $471,000 after acquiring an additional 6,354 shares during the last quarter. Virtu Financial LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter worth about $372,000. Novak & Powell Financial Services Inc. purchased a new position in shares of Healthpeak Properties in the 4th quarter worth about $206,000. Gillson Capital LP purchased a new position in shares of Healthpeak Properties in the 4th quarter worth about $1,261,000. Finally, Angelo Gordon & CO. L.P. purchased a new position in shares of Healthpeak Properties in the 4th quarter worth about $3,713,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
- Five stocks we like better than Healthpeak Properties
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 AI Stocks That You Can Buy and Hold Forever
- What is a buyback in stocks? A comprehensive guide for investors
- As The Magnificent 7 Stumble, Pivot to These 3 Growth Stocks
- What Are Dividend Challengers?
- Joby Aviation Stock: The Case for Upside Just Got Stronger
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.